SAN DIEGO—With plans to advance 10 drugs into the clinic over the next five years for a variety of disorders, Entos Pharmaceuticals didn’t want to depend on contract manufacturers for the drug ...
Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...
VANCOUVER, BC / ACCESSWIRE / September 23, 2022 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce it has entered into a ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using ...
Life science companies must adhere to the FDA’s Good Manufacturing Practices (GMP) in manufacturing and storage of the product within their manufacturing facility. For example, GMP compliance is ...
Peptides and oligonucleotides are transforming modern medicine. Peptide-based drugs have become the fastest-growing segment of chemically synthesized therapeutics, with over 80 approved worldwide, ...
Core One Labs (OTCQB:CLABF) acquired GMP Drug in a deal worth C$2.8M common stock plus bonus shares to pave the way to become a full-cycle psychedelics supply chain solution provider. Privately held ...
Advanced technologies in pharma manufacturing necessitate a redefinition of the Qualified Person's role, focusing on digital ...
“This renewal of our validation is a significant achievement for GrowerIQ and our clients,” said Andrew Wilson, CEO of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback